UK-headquartered pharma giant GlaxoSmithKline says it has overcome
the manufacturing problems that caused it to voluntarily withdraw
its antidepressant Paxil CR (paroxetine) and diabetes drug
Avandamet (metformin and rosiglitazone)...
UK company SkyePharma has shrugged off the news that production of
a GlaxoSmithKline drug based on its drug delivery technology, the
antidepressant Paxil CR (paroxetine), had been halted by the US
Food and Drug Administration (FDA).
UK company SkyePharma is expecting to achieve turnover of £100
million (€139m) in 2003, which would represent a rise of around 40
per cent over last year. However, the company has warned that the
lion's share of this total would...